Docosahexaenoic acid attenuates adipose tissue angiogenesis and insulin resistance in high fat diet-fed middle-aged mice via a sirt1-dependent mechanism

Molecular Nutrition and Food Research

Volumn 60, Issue 4, 2016, Pages 871-885

  Luo, Xiaoqin ^a,b   Jia, Ru ^a,b   Yao, Qinyu ^a   Xu, Yirui ^a   Luo, Zhenyu ^a   Luo, Xiao ^b   Wang, Nanping ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Adipose tissue; Angiogenesis; DHA; High fat diet; Sirt1

Indexed keywords

ANGIOGENESIS INHIBITOR; DOCOSAHEXAENOIC ACID; SIRT1 PROTEIN, MOUSE; SIRTUIN 1;

ADIPOCYTE; ADIPOSE TISSUE; ADVERSE EFFECTS; AGE; ANGIOGENESIS; ANIMAL; C57BL MOUSE; CELL SIZE; DIET THERAPY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; INSULIN RESISTANCE; LIPID DIET; MALE; METABOLISM; OBESITY; PANNICULITIS; VASCULARIZATION;

ADIPOCYTES; ADIPOSE TISSUE; AGE FACTORS; ANGIOGENESIS INHIBITORS; ANIMALS; CELL SIZE; DIET, HIGH-FAT; DOCOSAHEXAENOIC ACIDS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; INSULIN RESISTANCE; MALE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; OBESITY; PANNICULITIS; SIRTUIN 1;

EID: 84962647180     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201500714     Document Type: Article

References (66)

1. Kopelman, P. G., Obesity as a medical problem. Nature 2000, 404, 635-643.
2. Halberg, N., Khan, T., Trujillo, M. E., Wernstedt-Asterholm, I. et al., Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol. Cell. Biol. 2009, 29, 4467-4483.
3. Xu, H., Barnes, G. T., Yang, Q., Tan, G. et al., Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 2003, 112, 1821-1830.
4. Osborn, O., Olefsky, J. M., The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med. 2012, 18, 363-374.
5. Neels, J. G., Olefsky, J. M., Inflamed fat: what starts the fire? J. Clin. Invest. 2006, 116, 33-35.
6. Lumeng, C. N., Deyoung, S. M., Bodzin, J. L., Saltiel, A. R., Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes 2007, 56, 16-23.
7. Cancello, R., Tordjman, J., Poitou, C., Guilhem, G. et al., Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 2006, 55, 1554-1561.
8. Tang, W., Zeve, D., Suh, J. M., Bosnakovski, D. et al., White fat progenitor cells reside in the adipose vasculature. Science 2008, 322, 583-586.
9. Unger, R. H., Scherer, P. E., Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity. Trends Endocrinol. Metab. 2010, 21, 345-352.
10. Sun, K., Kusminski, C. M., Scherer, P. E., Adipose tissue remodeling and obesity. J. Clin. Invest. 2011, 121, 2094-2101.
11. Spencer, M., Finlin, B. S., Unal, R., Zhu, B. et al., Omega-3 fatty acids reduce adipose tissue macrophages in human subjects with insulin resistance. Diabetes 2013, 62, 1709-1717.
12. Flock, M. R., Rogers, C. J., Prabhu, K. S., Kris-Etherton, P. M., Immunometabolic role of long-chain omega-3 fatty acids in obesity-induced inflammation. Diabetes Metab. Res. Rev. 2013, 29, 431-445.
13. D'Archivio, M., Scazzocchio, B., Giammarioli, S., Fiani, M. L. et al., omega3-PUFAs exert anti-inflammatory activity in visceral adipocytes from colorectal cancer patients. PLoS One 2013, 8, e77432.
14. Szymczak, M., Murray, M., Petrovic, N., Modulation of angiogenesis by omega-3 polyunsaturated fatty acids is mediated by cyclooxygenases. Blood 2008, 111, 3514-3521.
15. Zhang, G., Panigrahy, D., Mahakian, L. M., Yang, J. et al., Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis. Proc. Natl. Acad. Sci. U S A 2013, 110, 6530-6535.
16. Blander, G., Guarente, L., The Sir2 family of protein deacetylases. Annu. Rev. Biochem. 2004, 73, 417-435.
17. Bordone, L., Guarente, L., Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat. Rev. Mol. Cell. Biol. 2005, 6, 298-305.
18. Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A. et al., Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 2004, 429, 771-776.
19. Xue, B., Yang, Z., Wang, X., Shi, H., Omega-3 polyunsaturated fatty acids antagonize macrophage inflammation via activation of AMPK/SIRT1 pathway. PLoS One 2012, 7, e45990.
20. Luo, X., Hutley, L. J., Webster, J. A., Kim, Y. H. et al., Identification of BMP and activin membrane-bound inhibitor (BAMBI) as a potent negative regulator of adipogenesis and modulator of autocrine/paracrine adipogenic factors. Diabetes 2012, 61, 124-136.
21. Qiao, L., Shao, J., SIRT1 regulates adiponectin gene expression through Foxo1-C/enhancer-binding protein alpha transcriptional complex. J. Biol. Chem. 2006, 281, 39915-39924.
22. Ferrante, A. J., The immune cells in adipose tissue. Diabetes Obes. Metab. 2013, 15 Suppl 3, 34-38.
23. Lu, X., Ji, Y., Zhang, L., Zhang, Y. et al., Resistance to obesity by repression of VEGF gene expression through induction of brown-like adipocyte differentiation. Endocrinology 2012, 153, 3123-3132.
24. Honek, J., Seki, T., Iwamoto, H., Fischer, C. et al., Modulation of age-related insulin sensitivity by VEGF-dependent vascular plasticity in adipose tissues. Proc. Natl. Acad. Sci. U S A 2014, 111, 14906-14911.
25. Ledoux, S., Queguiner, I., Msika, S., Calderari, S. et al., Angiogenesis associated with visceral and subcutaneous adipose tissue in severe human obesity. Diabetes 2008, 57, 3247-3257.
26. Michailidou, Z., Turban, S., Miller, E., Zou, X. et al., Increased angiogenesis protects against adipose hypoxia and fibrosis in metabolic disease-resistant 11beta-hydroxysteroid dehydrogenase type 1 (HSD1)-deficient mice. J. Biol. Chem. 2012, 287, 4188-4197.
27. Hodson, L., Humphreys, S. M., Karpe, F., Frayn, K. N., Metabolic signatures of human adipose tissue hypoxia in obesity. Diabetes 2013, 62, 1417-1425.
28. Brakenhielm, E., Cao, R., Gao, B., Angelin, B. et al., Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice. Circ. Res. 2004, 94, 1579-1588.
29. Rupnick, M. A., Panigrahy, D., Zhang, C. Y., Dallabrida, S. M. et al., Adipose tissue mass can be regulated through the vasculature. Proc. Natl. Acad. Sci. U S A 2002, 99, 10730-10735.
30. Chao, C. Y., Lii, C. K., Ye, S. Y., Li, C. C. et al., Docosahexaenoic acid inhibits vascular endothelial growth factor (VEGF)-induced cell migration via the GPR120/PP2A/ERK1/2/eNOS signaling pathway in human umbilical vein endothelial cells. J. Agric. Food Chem. 2014, 62, 4152-4158.
31. Cao, R., Brakenhielm, E., Wahlestedt, C., Thyberg, J. et al., Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc. Natl. Acad. Sci. U S A 2001, 98, 6390-6395.
32. Schneider, D. J., Sobel, B. E., PAI-1 and diabetes: a journey from the bench to the bedside. Diabetes Care 2012, 35, 1961-1967.
33. Xue, Y., Petrovic, N., Cao, R., Larsson, O. et al., Hypoxia-independent angiogenesis in adipose tissues during cold acclimation. Cell Metab. 2009, 9, 99-109.
34. Hosogai, N., Fukuhara, A., Oshima, K., Miyata, Y. et al., Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 2007, 56, 901-911.
35. Trayhurn, P., Wang, B., Wood, I. S., Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? Br. J. Nutr. 2008, 100, 227-235.
36. Tam, J., Duda, D. G., Perentes, J. Y., Quadri, R. S. et al., Blockade of VEGFR2 and not VEGFR1 can limit diet-induced fat tissue expansion: role of local versus bone marrow-derived endothelial cells. PLoS One 2009, 4, e4974.
37. Elias, I., Franckhauser, S., Ferre, T., Vila, L. et al., Adipose tissue overexpression of vascular endothelial growth factor protects against diet-induced obesity and insulin resistance. Diabetes 2012, 61, 1801-1813.
38. Cao, R., Brakenhielm, E., Wahlestedt, C., Thyberg, J. et al., Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc. Natl. Acad. Sci. U S A 2001, 98, 6390-6395.
39. Martin, D., Galisteo, R., Gutkind, J. S., CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex. J. Biol. Chem. 2009, 284, 6038-6042.
40. Kiec-Wilk, B., Czech, U., Janczarska, K., Knapp, A. et al., Connexin 43 and metabolic effect of fatty acids in stressed endothelial cells. Genes Nutr. 2012, 7, 257-263.
41. Ruscher, K., Freyer, D., Karsch, M., Isaev, N. et al., Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J. Neurosci. 2002, 22, 10291-10301.
42. Suganami, T., Nishida, J., Ogawa, Y., A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 2062-2068.
43. Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M. et al., Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112, 1796-1808.
44. Gunawardana, S. C., Benefits of healthy adipose tissue in the treatment of diabetes. World J. Diabetes 2014, 5, 420-430.
45. Wang, J., Badeanlou, L., Bielawski, J., Ciaraldi, T. P., Sphingosine kinase 1 regulates adipose proinflammatory responses and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 2014, 306, E756-E768.
46. Shen, W., Wolf, P. G., Carbonero, F., Zhong, W. et al., Intestinal and systemic inflammatory responses are positively associated with sulfidogenic bacteria abundance in high-fat-fed male C57BL/6J mice. J. Nutr. 2014, 144, 1181-1187.
47. Villaret, A., Galitzky, J., Decaunes, P., Esteve, D. et al., Adipose tissue endothelial cells from obese human subjects: differences among depots in angiogenic, metabolic, and inflammatory gene expression and cellular senescence. Diabetes 2010, 59, 2755-2763.
48. De Boer, A. A., Monk, J. M., Robinson, L. E., Docosahexaenoic acid decreases pro-inflammatory mediators in an in vitro murine adipocyte macrophage co-culture model. PLoS One 2014, 9, e85037.
49. Oster, R. T., Tishinsky, J. M., Yuan, Z., Robinson, L. E., Docosahexaenoic acid increases cellular adiponectin mRNA and secreted adiponectin protein, as well as PPARgamma mRNA, in 3T3-L1 adipocytes. Appl. Physiol. Nutr. Metab. 2010, 35, 783-789.
50. Milne, J. C., Denu, J. M., The Sirtuin family: therapeutic targets to treat diseases of aging. Curr. Opin. Chem. Biol. 2008, 12, 11-17.
51. Pfluger, P. T., Herranz, D., Velasco-Miguel, S., Serrano, M., Tschop, M. H., Sirt1 protects against high-fat diet-induced metabolic damage. Proc. Natl. Acad. Sci. U S A 2008, 105, 9793-9798.
52. Milne, J. C., Lambert, P. D., Schenk, S., Carney, D. P. et al., Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 2007, 450, 712-716.
53. Moynihan, K. A., Grimm, A. A., Plueger, M. M., Bernal-Mizrachi, E. et al., Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice. Cell Metab. 2005, 2, 105-117.
54. Sun, C., Zhang, F., Ge, X., Yan, T. et al., SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab. 2007, 6, 307-319.
55. Xu, F., Burk, D., Gao, Z., Yin, J. et al., Angiogenic deficiency and adipose tissue dysfunction are associated with macrophage malfunction in SIRT1-/- mice. Endocrinology 2012, 153, 1706-1716.
56. Potente, M., Ghaeni, L., Baldessari, D., Mostoslavsky, R. et al., SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev. 2007, 21, 2644-2658.
57. Lim, J. H., Lee, Y. M., Chun, Y. S., Chen, J. et al., Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol. Cell 2010, 38, 864-878.
58. Kim, H. J., Vosseler, C. A., Weber, P. C., Erl, W., Docosahexaenoic acid induces apoptosis in proliferating human endothelial cells. J. Cell. Physiol. 2005, 204, 881-888.
59. Song, N. Y., Na, H. K., Baek, J. H., Surh, Y. J., Docosahexaenoic acid inhibits insulin-induced activation of sterol regulatory-element binding protein 1 and cyclooxygenase-2 expression through upregulation of SIRT1 in human colon epithelial cells. Biochem. Pharmacol. 2014, 92, 142-148.
60. Kim, J. J., Kim, S. J., Kim, Y. S., Kim, S. Y. et al., The role of SIRT1 on angiogenic and odontogenic potential in human dental pulp cells. J. Endod. 2012, 38, 899-906.
61. Yoon, H., Shin, S. H., Shin, D. H., Chun, Y. S., Park, J. W., Differential roles of Sirt1 in HIF-1alpha and HIF-2alpha mediated hypoxic responses. Biochem. Biophys. Res. Commun. 2014, 444, 36-43.
62. Li, Y., Zhu, W., Li, J., Liu, M., Wei, M., Resveratrol suppresses the STAT3 signaling pathway and inhibits proliferation of high glucose-exposed HepG2 cells partly through SIRT1. Oncol. Rep. 2013, 30, 2820-2828.
63. Qiao, L., Shao, J., SIRT1 regulates adiponectin gene expression through Foxo1-C/enhancer-binding protein alpha transcriptional complex. J. Biol. Chem. 2006, 281, 39915-39924.
64. Zu, Y., Liu, L., Lee, M. Y., Xu, C. et al., SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells. Circ. Res. 2010, 106, 1384-1393.
65. Xie, Z., Dong, Y., Zhang, J., Scholz, R. et al., Identification of the serine 307 of LKB1 as a novel phosphorylation site essential for its nucleocytoplasmic transport and endothelial cell angiogenesis. Mol. Cell. Biol. 2009, 29, 3582-3596.
66. Potente, M., Ghaeni, L., Baldessari, D., Mostoslavsky, R. et al., SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev. 2007, 21, 2644-2658.